tiprankstipranks
Trending News
More News >
Axilion Smart Mobility Ltd. (IL:AILN)
:AILN
Israel Market
Advertisement

Axilion (AILN) AI Stock Analysis

Compare
0 Followers

Top Page

IL:AILN

Axilion

(AILN)

Rating:45Neutral
Price Target:
29.00
▼(-11.04% Downside)
Axilion's overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. Despite some neutral to slightly positive technical indicators, the company's negative income and cash flow margins, combined with a negative P/E ratio, result in a low overall score. Without significant financial restructuring or operational improvements, the stock remains a high-risk investment.

Axilion (AILN) vs. iShares MSCI Israel ETF (EIS)

Axilion Business Overview & Revenue Model

Company DescriptionAxilion (AILN) is a technology company specializing in artificial intelligence and smart mobility solutions. The company focuses on developing software platforms that enhance urban transportation systems, improve traffic flow, and reduce emissions in cities. Axilion's core products leverage AI and machine learning to optimize traffic signals and public transport operations, helping municipalities and transit authorities create more efficient and sustainable urban environments.
How the Company Makes MoneyAxilion makes money primarily through the sale and licensing of its AI-driven software solutions to city governments and transportation agencies. The company generates revenue by entering into contracts for the deployment and ongoing support of its traffic optimization platforms. These platforms use real-time data to improve traffic management, thus providing value in terms of reduced congestion and environmental impact. Axilion may also enter into strategic partnerships with other companies and technology providers to integrate its solutions into broader smart city initiatives, potentially leading to additional revenue streams.

Axilion Financial Statement Overview

Summary
Axilion is facing significant financial difficulties, highlighted by negative income margins, declining equity, and severe liquidity issues. Despite a revenue growth rate of 15.78%, ongoing losses, negative cash flows, and reliance on equity financing indicate a weak financial position.
Income Statement
25
Negative
Axilion's income statement reveals significant challenges. Despite an increase in revenue from 2023 to 2024, the company has consistently reported negative gross profit margins, indicating that its costs exceed its revenues. The net profit margin remains negative, showcasing ongoing losses. EBIT and EBITDA margins are also negative, reflecting a lack of operational profitability. The revenue growth rate of 15.78% from 2023 to 2024 is a positive note, but it is overshadowed by the persistent negative margins.
Balance Sheet
30
Negative
The balance sheet shows a company that is heavily reliant on equity financing with a low debt-to-equity ratio of 0.29 in 2024. However, the equity ratio has decreased significantly from 2023 to 2024, indicating declining financial stability. Return on Equity (ROE) remains negative due to sustained losses, and the overall financial health is weak despite manageable debt levels.
Cash Flow
20
Very Negative
Axilion's cash flow statements highlight severe liquidity issues, with negative operating and free cash flows. Although the operating cash flow to net income ratio is close to 1, indicating consistency in cash burn relative to net losses, the lack of positive free cash flow growth and negative free cash flow to net income ratio underscores the firm's inability to generate cash from operations.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.22M1.91M1.26M2.14M1.53M
Gross Profit-1.21M-1.45M-2.53M-2.96M1.63K
EBITDA-21.82M-22.88M-21.82M-28.67M-281.25M
Net Income-23.08M-24.24M-23.10M-30.24M-281.54M
Balance Sheet
Total Assets21.09M35.25M56.92M78.24M42.56M
Cash, Cash Equivalents and Short-Term Investments16.33M32.54M53.73M73.26M39.75M
Total Debt3.68M1.28M1.94M2.39M1.46M
Total Liabilities8.18M6.04M6.02M7.08M5.81M
Stockholders Equity12.91M29.21M50.90M71.16M36.76M
Cash Flow
Free Cash Flow-20.42M-20.47M-19.70M-25.02M-13.60M
Operating Cash Flow-20.39M-20.39M-19.59M-24.55M-13.19M
Investing Cash Flow16.84M7.38M347.00K-25.37M-588.64K
Financing Cash Flow4.41M-847.00K-403.00K58.85M34.26M

Axilion Technical Analysis

Technical Analysis Sentiment
Positive
Last Price32.60
Price Trends
50DMA
29.98
Positive
100DMA
28.01
Positive
200DMA
34.65
Negative
Market Momentum
MACD
0.71
Positive
RSI
54.17
Neutral
STOCH
46.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AILN, the sentiment is Positive. The current price of 32.6 is above the 20-day moving average (MA) of 31.99, above the 50-day MA of 29.98, and below the 200-day MA of 34.65, indicating a neutral trend. The MACD of 0.71 indicates Positive momentum. The RSI at 54.17 is Neutral, neither overbought nor oversold. The STOCH value of 46.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:AILN.

Axilion Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
£500.75M27.110.85%2.82%3.88%-21.07%
46
Neutral
186.88M
238.35%-0.43%
45
Neutral
16.31M
15.78%27.57%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:AILN
Axilion
32.10
-7.72
-19.39%
IL:RZR
Razor Labs
474.80
114.10
31.63%

Axilion Corporate Events

Axilion Updates Convertible Securities Terms After Rights Offering
Feb 17, 2025

Axilion has announced an update to the terms of its convertible securities following a rights offering. This move signifies Axilion’s strategic financial adjustments which may affect its standing on the Tel Aviv Stock Exchange and could have implications for its stakeholders as the company continues to evolve in the financial market.

Axilion Announces Upcoming Investors’ Conference via Zoom
Feb 17, 2025

Axilion has announced an upcoming investors’ conference to be held via an online Zoom webinar. The conference is a significant event for stakeholders as it underscores Axilion’s commitment to transparency and engagement with investors, with the company’s securities being traded on the Tel Aviv Stock Exchange.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2025